AU2001247453A1 - Genetically stable cholera vaccines - Google Patents

Genetically stable cholera vaccines

Info

Publication number
AU2001247453A1
AU2001247453A1 AU2001247453A AU4745301A AU2001247453A1 AU 2001247453 A1 AU2001247453 A1 AU 2001247453A1 AU 2001247453 A AU2001247453 A AU 2001247453A AU 4745301 A AU4745301 A AU 4745301A AU 2001247453 A1 AU2001247453 A1 AU 2001247453A1
Authority
AU
Australia
Prior art keywords
genetically stable
cholera vaccines
stable cholera
vaccines
genetically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001247453A
Inventor
Claudia Hase
John J. Mekalanos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard College
St Jude Childrens Research Hospital
Original Assignee
Harvard College
St Jude Childrens Research Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College, St Jude Childrens Research Hospital filed Critical Harvard College
Publication of AU2001247453A1 publication Critical patent/AU2001247453A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001247453A 2000-03-16 2001-03-16 Genetically stable cholera vaccines Abandoned AU2001247453A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52634400A 2000-03-16 2000-03-16
US09526344 2000-03-16
PCT/US2001/008305 WO2001068829A2 (en) 2000-03-16 2001-03-16 Genetically stable cholera vaccines

Publications (1)

Publication Number Publication Date
AU2001247453A1 true AU2001247453A1 (en) 2001-09-24

Family

ID=24096949

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001247453A Abandoned AU2001247453A1 (en) 2000-03-16 2001-03-16 Genetically stable cholera vaccines

Country Status (2)

Country Link
AU (1) AU2001247453A1 (en)
WO (1) WO2001068829A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1493813A1 (en) * 2003-07-03 2005-01-05 Facultés Universitaires Notre-Dame de la Paix Flagellar genetic sequences of Brucella being of therapeutic and diagnostic use
WO2011100489A2 (en) * 2010-02-12 2011-08-18 The Brigham And Women's Hospital, Inc. Improved live bacterial vaccine safety
US9845341B2 (en) 2013-03-11 2017-12-19 The Brigham And Women's Hospital, Inc. Vibro-based delivery system and immune suppression
CN106290850A (en) * 2015-05-13 2017-01-04 上海凯创生物技术有限公司 Cholera vibrio O 139 emulsion technique detection kit
US11484585B2 (en) 2017-07-12 2022-11-01 The Brigham And Women's Hospital, Inc. Live attenuated cholera vaccine with probiotic properties
MY190074A (en) * 2018-01-09 2022-03-24 Aimst Univ A monovalent vaccine formulation and a method for preparation thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995018633A1 (en) * 1994-01-06 1995-07-13 President And Fellows Of Harvard College Soft agar penetration-defective mutants

Also Published As

Publication number Publication date
WO2001068829A2 (en) 2001-09-20
WO2001068829A3 (en) 2002-03-21

Similar Documents

Publication Publication Date Title
HUP0202885A3 (en) Vaccines
AU3198200A (en) Prrsv vaccines
AU4433702A (en) Vaccines
AU2001258117A1 (en) Supports for photosensitizer formulations
AU2001280908A1 (en) Rotavirus vaccine formulations
AU2001258279A1 (en) Adjuvant for vaccines
AUPQ520800A0 (en) Prime-boost vaccination strategy
AU5977700A (en) Vaccines
GB9901254D0 (en) Vaccines
AU1600401A (en) Malaria vaccine
AU2001247453A1 (en) Genetically stable cholera vaccines
AU2001269408A1 (en) Miniature thermal device
AU6158700A (en) Vaccine
AU2001278323A1 (en) Modified sialic acid vaccines
AU2002254161A1 (en) M cell directed vaccines
AU2001267541A1 (en) Vaccine composition
AU2001286775A1 (en) Adjuvant
AU2002222139A1 (en) Hcv vaccines
AU5811600A (en) Vaccine
AU1101701A (en) Vaccine compositions
AU2767201A (en) M cell directed vaccines
AU5084300A (en) New vaccine formulations - 1
AU2001251761A1 (en) Equine protozoal myeloencephalitis vaccine
GB0004533D0 (en) Vaccines
AU2001266534A1 (en) Papillomavirus vaccine